BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2255853)

  • 1. Recognition of ICRC and Mycobacterium leprae antigens by sera from leprosy patients.
    Chiplunkar SV; Kudalkar JL; Butlin R; Deo MG; Gangal SG
    Trop Med Parasitol; 1990 Sep; 41(3):317-8. PubMed ID: 2255853
    [No Abstract]   [Full Text] [Related]  

  • 2. Major proteins of mycobacterial strain ICRC and Mycobacterium leprae, identified by antibodies in sera from leprosy patients and their contacts.
    Chiplunkar SV; Kudalkar JL; Butlin R; Samson PD; Deo MG; Gangal SG
    J Clin Microbiol; 1992 Feb; 30(2):336-41. PubMed ID: 1537902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic similarity of a cultivable acid fast bacterium to Mycobacterium leprae.
    Joshi S; Nair SC; Mahadevan PR
    Indian J Med Res; 1993 Jan; 97():18-24. PubMed ID: 8486404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avidin-biotin immunoblotting studies on reactivity of leprosy sera with Mycobacterium leprae antigen.
    Patil SA; Shivraj L; Girdhar BK; Sengupta U
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):280-3. PubMed ID: 1522374
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoreactivity of mycobacterial strain ICRC and Mycobacterium leprae antigens with polyclonal and monoclonal antibodies.
    Chiplunkar SV; Kudalkar JL; Gangal SG; Deo MG
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):421-7. PubMed ID: 8228441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactions to antigens from actinomycetes including Mycobacterium leprae in leprosy patients.
    Ohman R; Walford C; Converse P; Ridell M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):320-2. PubMed ID: 2071990
    [No Abstract]   [Full Text] [Related]  

  • 8. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.
    Gormus BJ; Meyers WM
    Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immuno-blot analysis of antigens of Mycobacterium w: a candidate anti-leprosy vaccine using monoclonal antibodies and patient sera.
    Ganju L; Mukherjee R; Batra HV; Talwar GP
    Zentralbl Bakteriol; 1990 Aug; 273(3):378-85. PubMed ID: 1698376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoprecipitation of mycobacterial antigens with sera from patients with leprosy.
    Kode JA; Chiplunkar SV; Samson PD; Deo MG; Gangal SG
    Acta Leprol; 1994; 9(2):89-94. PubMed ID: 7863757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective properties of M. lufu in experimental leprosy].
    Iushin MIu; Kalianina OV
    Probl Tuberk; 1995; (2):47-8. PubMed ID: 7777465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of non-conventional antigen: M. habana in detecting M. leprae antibodies from leprosy patients and contacts in FLA-ABS test.
    Rana NS; Gupta HP; Singh NB
    Indian J Lepr; 1988 Oct; 60(4):593-9. PubMed ID: 3075637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human vaccination studies in normal and contacts of leprosy patients.
    Samuel NM; Stanford JL; Rees RJ; Fairbairn T; Adiga RB
    Indian J Lepr; 1984; 56(1):36-47. PubMed ID: 6384380
    [No Abstract]   [Full Text] [Related]  

  • 14. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for new generation vaccines for leprosy: progress, barriers, and future strategies.
    Watson JD
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):834-43. PubMed ID: 2681465
    [No Abstract]   [Full Text] [Related]  

  • 16. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to antigens from cultivable saprophytic mycobacteria.
    Sharma RC; Singh R
    Lepr India; 1978 Oct; 50(4):572-8. PubMed ID: 374876
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoclonal antibodies against Mycobacterium leprae and their applications in leprosy research.
    Sengupta U; Sinha S
    Indian J Lepr; 1984; 56(4):727-41. PubMed ID: 6398337
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigens of Mycobacterium leprae identified by immunoprecipitation with sera from leprosy and tuberculosis patients.
    Britton WJ; Hellqvist L; Garsia RJ; Basten A
    Clin Exp Immunol; 1988 Mar; 71(3):394-8. PubMed ID: 3289801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delipidified cell components of Mycobacterium leprae and its applications.
    Mahadevan PR; Robinson P; Vermani M; Pardhy A; Joshi S
    Indian J Lepr; 1991; 63(3-4):371-87. PubMed ID: 1804891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.